Salka Michael Scott 4
4 · Sorrento Therapeutics, Inc. · Filed Feb 27, 2012
Insider Transaction Report
Form 4
Salka Michael Scott
Director
Transactions
- Award
Non-qualified stock options
2012-02-23+60,000→ 60,000 totalExercise: $0.16From: 2013-02-23Exp: 2022-02-23→ Common Stock (60,000 underlying)